Sat Kartar Shopping Ltd
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company that delivers natural wellness solutions for therapeutic and lifestyle products.[1]
- Market Cap ₹ 315 Cr.
- Current Price ₹ 200
- High / Low ₹ 238 / 124
- Stock P/E
- Book Value ₹ 36.8
- Dividend Yield 0.34 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.39 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 38% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Average Ticket Size per Order INR ・Standalone data |
|
|
| Consumer Database Size Million ・Standalone data |
||
| Daily Unique Leads Generated Number ・Standalone data |
||
| Number of Call / Wellness Executives Number ・Standalone data |
||
| Number of Manufacturing Facilities (Contract/Owned) Number ・Standalone data |
||
| Number of SKUs Number ・Standalone data |
||
| Pincodes Covered Across India Number ・Standalone data |
||
| Total Employee Strength Number ・Standalone data |
||
Extracted by Screener AI
Documents
Announcements
-
Updates
22 April 2026 - Sat Kartar Life Limited confirms it is not a Large Corporate; outstanding borrowing was Rs 2,39,02,265.20 as of 31 March 2026.
-
Copy of Newspaper Publication
22 April 2026 - Newspaper publication confirms EGM notice dispatch and remote e-voting; EGM scheduled for 13 May 2026.
-
Shareholders meeting
21 April 2026 - EGM on May 13 to approve ₹86.69 lakh shares and ₹47.72 crore warrants preferential issue.
-
Copy of Newspaper Publication
20 April 2026 - Published EGM newspaper ads on 20 Apr 2026; EGM on 13 May 2026 at 10:00 AM via VC/OAVM.
-
Acquisition
18 April 2026 - Board approved buying additional 24% in Plantomed Nutraceuticals for ₹1.21 crore; completion expected by 15 May 2026.
Annual reports
Concalls
-
Nov 2025TranscriptPPT
-
Nov 2025Transcript PPT REC
-
Oct 2025TranscriptAI SummaryPPT
-
May 2025Transcript PPT REC
Business Model[1]
The company operates in the Ayurveda healthcare sector using a Direct-to-Consumer (D2C) model, combining Ayurvedic principles with modern research. It focuses on product innovation, branding, and marketing while outsourcing manufacturing to trusted partners, adopting an asset-light strategy.